Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China
Authors
Xi Lu (ORCID: https://orcid.org/0000-0003-3297-5198)
Kang-Ning Wang
Yunfeng Shi (ORCID: https://orcid.org/0000-0003-0832-2832)
Hongxing Pan (ORCID: https://orcid.org/0000-0002-3791-1241)
Yanwei Zhao
Li Ju (ORCID: https://orcid.org/0000-0002-5660-3949)
Yu-Ying Zou
Wen-tao Zou
Yu Pan
Ming-wei Wei
Ling Tuo
Institutions
Sinovac Biotech (CN)
Jiangsu Provincial Center for Disease Control and Prevention (CN)
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China
Xi Lu, Kang-Ning Wang, Yunfeng Shi, Hongxing Pan et al.
Journal
Infectious Diseases and Therapy
Topics
Pneumonia and Respiratory Infections
article
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China
Xi Lu, Kang-Ning Wang, Yunfeng Shi, Hongxing Pan, Yanwei Zhao, Li Ju, Yu-Ying Zou, Wen-tao Zou, Yu Pan, Ming-wei Wei, Ling Tuo
article en
Abstract
No abstract available for this paper.
Publication Tag
Infectious Diseases and Therapy
Institutions
Sinovac Biotech (CN), Jiangsu Provincial Center for Disease Control and Prevention (CN), Nanjing Medical University (CN)